Answers are grounded in this paper and cite their sources.
Evaluates the effectiveness of Phesgo in HER2-positive breast cancer, suggesting faster administration benefits.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Tatsuno et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: